Back to 
JACOBS LEVY EQUITY MANAGEMENT, INC
JACOBS LEVY EQUITY MANAGEMENT, INC
PRAX
Showing 7 of 10 quarters
Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in PRAXIS PRECISION MEDICINES I
No. Jacobs Levy Equity Management exited its PRAX (Praxis Precision Medicines) position in Q1 2026. Its Q4 2025 13F listed 10,140 shares worth $3M. Jacobs Levy Equity Management already held PRAX in its Q4 2023 13F, the earliest on record, and held it in 9 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.3M
Total Shares Change
-39,999
Quarter-by-Quarter History